Ann Hynes
Stock Analyst at Mizuho
(5.00)
# 1
Out of 4,784 analysts
233
Total ratings
67.07%
Success rate
192.66%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $48 → $37 | $30.12 | +22.84% | 10 | Mar 25, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $382 → $376 | $322.85 | +16.46% | 7 | Mar 3, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $177 → $178 | $167.33 | +6.38% | 13 | Feb 3, 2025 | |
| MD Pediatrix Medical Group | Maintains: Neutral | $13 → $15 | $14.16 | +5.93% | 11 | Nov 19, 2024 | |
| ELV Elevance Health | Maintains: Outperform | $585 → $505 | $432.00 | +16.90% | 3 | Nov 5, 2024 | |
| CAH Cardinal Health | Maintains: Neutral | $110 → $120 | $136.44 | -12.05% | 8 | Nov 4, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Outperform | $17 → $20 | $18.03 | +10.93% | 1 | Nov 4, 2024 | |
| CVS CVS Health | Maintains: Outperform | $73 → $66 | $67.14 | -1.70% | 9 | Oct 24, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Outperform | $28 | $21.44 | +30.60% | 1 | Aug 19, 2024 | |
| ARDT Ardent Health Partners | Initiates: Outperform | $20 | $13.20 | +51.52% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $235 | $155.55 | +51.08% | 1 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $27 | $8.03 | +236.24% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $435 | $312.36 | +39.26% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 → $130 | $133.14 | -2.36% | 14 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $100.78 | -5.74% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $346 | $179.07 | +93.22% | 13 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $325.04 | +18.45% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $186.18 | +7.42% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $2.25 | +11,811.11% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $668.06 | -24.41% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $550 → $400 | $264.58 | +51.18% | 7 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $230.02 | -0.01% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $342.16 | -19.63% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $11.19 | +123.41% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $229 | $177.39 | +29.09% | 10 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $23.95 | +108.77% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $600 → $549 | $516.04 | +6.39% | 16 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $76 | $60.04 | +26.58% | 7 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.41 | +3,942.55% | 1 | Sep 21, 2017 |
Acadia Healthcare Company
Mar 25, 2025
Maintains: Neutral
Price Target: $48 → $37
Current: $30.12
Upside: +22.84%
Molina Healthcare
Mar 3, 2025
Maintains: Outperform
Price Target: $382 → $376
Current: $322.85
Upside: +16.46%
Quest Diagnostics
Feb 3, 2025
Maintains: Outperform
Price Target: $177 → $178
Current: $167.33
Upside: +6.38%
Pediatrix Medical Group
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $14.16
Upside: +5.93%
Elevance Health
Nov 5, 2024
Maintains: Outperform
Price Target: $585 → $505
Current: $432.00
Upside: +16.90%
Cardinal Health
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $136.44
Upside: -12.05%
BrightSpring Health Services
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $18.03
Upside: +10.93%
CVS Health
Oct 24, 2024
Maintains: Outperform
Price Target: $73 → $66
Current: $67.14
Upside: -1.70%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $21.44
Upside: +30.60%
Ardent Health Partners
Aug 12, 2024
Initiates: Outperform
Price Target: $20
Current: $13.20
Upside: +51.52%
Jun 7, 2024
Initiates: Neutral
Price Target: $235
Current: $155.55
Upside: +51.08%
May 28, 2024
Initiates: Neutral
Price Target: $27
Current: $8.03
Upside: +236.24%
May 28, 2024
Initiates: Buy
Price Target: $435
Current: $312.36
Upside: +39.26%
May 1, 2024
Reiterates: Buy
Price Target: $118 → $130
Current: $133.14
Upside: -2.36%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $100.78
Upside: -5.74%
Apr 4, 2024
Reiterates: Buy
Price Target: $346
Current: $179.07
Upside: +93.22%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $325.04
Upside: +18.45%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $186.18
Upside: +7.42%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $2.25
Upside: +11,811.11%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $668.06
Upside: -24.41%
Jan 26, 2024
Maintains: Buy
Price Target: $550 → $400
Current: $264.58
Upside: +51.18%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $230.02
Upside: -0.01%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $342.16
Upside: -19.63%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $11.19
Upside: +123.41%
Oct 10, 2023
Maintains: Buy
Price Target: $250 → $229
Current: $177.39
Upside: +29.09%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $23.95
Upside: +108.77%
Jul 11, 2023
Maintains: Buy
Price Target: $600 → $549
Current: $516.04
Upside: +6.39%
Jul 11, 2023
Maintains: Neutral
Price Target: $80 → $76
Current: $60.04
Upside: +26.58%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.41
Upside: +3,942.55%